Literature DB >> 8005262

From granuloma to fibrosis in interstitial lung diseases: molecular and cellular interactions.

J F Mornex1, C Leroux, T Greenland, D Ecochard.   

Abstract

Granuloma is a feature of many chronic interstitial lung diseases, and may serve as a focus for subsequent fibrosis. Granulomas are composed of structured masses of cells of the macrophage lineage, which adopt an epithelioid aspect, interspersed with lymphocytes. They are formed around local centres of irritation. During their resolution, fibroblasts congregate around the structures and may penetrate the interior. In many cases, granulomas can disappear without leaving lasting traces. However, especially when damage has occurred to the surrounding tissue, permanent scarring and fibrosis may occur. Both types of cell present in the granuloma are capable of secreting a number of factors influencing the accumulation and proliferation of fibroblasts, both positively and negatively. The possible roles played by the different factors and, especially, interactions between them are discussed in the light of fibrosis formation. Possible therapeutic interventions are summarized.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005262     DOI: 10.1183/09031936.94.07040779

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

Review 1.  Anti-TNFα therapy in inflammatory lung diseases.

Authors:  Rama Malaviya; Jeffrey D Laskin; Debra L Laskin
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

2.  Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells.

Authors:  Carlo Vancheri; Claudio Mastruzzo; Elisa Trovato-Salinaro; Elisa Gili; Debora Lo Furno; Maria P Pistorio; Massimo Caruso; Cristina La Rosa; Claudia Crimi; Marco Failla; Nunzio Crimi
Journal:  Respir Res       Date:  2005-09-13

3.  Role of ICAM-1 in the aggregation and adhesion of human alveolar macrophages in response to TNF-alpha and INF-gamma.

Authors:  M Sasaki; Y Namioka; T Ito; N Izumiyama; S Fukui; A Watanabe; M Kashima; M Sano; T Shioya; M Miura
Journal:  Mediators Inflamm       Date:  2001-12       Impact factor: 4.711

Review 4.  Multinucleated Giant Cells: Current Insights in Phenotype, Biological Activities, and Mechanism of Formation.

Authors:  Kourosh Ahmadzadeh; Margot Vanoppen; Carlos D Rose; Patrick Matthys; Carine Helena Wouters
Journal:  Front Cell Dev Biol       Date:  2022-04-11

5.  BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity.

Authors:  Edvardas Danila; Laimute Jurgauskiene; Jolita Norkuniene; Radvile Malickaite
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

6.  Improvement with infliximab of a disseminated sarcoidosis in a patient with Crohn's disease.

Authors:  Nader Chebib; Fabrice Piégay; Julie Traclet; François Mion; Jean-François Mornex
Journal:  Case Rep Pulmonol       Date:  2014-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.